Superiority of three-dimensional stem cell clusters over monolayer culture: An archetype to biological application

被引:7
作者
Regmi, Shobha [1 ]
Jeong, Jee-Heon [1 ]
机构
[1] Yeungnam Univ, Coll Pharm, Gyongsan 38541, Gyeongbuk, South Korea
基金
新加坡国家研究基金会;
关键词
mesenchymal stem cells; three-dimensional (3D) culture; cell-based therapeutics; spheroids; MESENCHYMAL STROMAL CELLS; MULTICELLULAR TUMOR SPHEROIDS; IN-VITRO; REGENERATIVE MEDICINE; EMBRYOID BODIES; MYOGENIC DIFFERENTIATION; HEPATOCYTE SPHEROIDS; FORCED AGGREGATION; CANCER METASTASIS; 3D CULTURE;
D O I
10.1007/s13233-016-4107-4
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) are attractive and potential alternatives to cell-based therapeutics in the field of regenerative medicine. Various clinical trials are being conducted to investigate the therapeutic efficacy of MSCs in a variety of diseases. Many studies show three-dimensional (3D) aggregates as more physiologically relevant than conventional two-dimensional (2D) cultures. Cell morphology, viability, functionality, as well as various gene expressions at the molecular level are drastically changed after 3D culture. MSCs as 3D aggregates provide enhanced differentiation potential and upregulation of pluripotency markers that subsequently result in stemness of MSCs. Furthermore, other biological properties like angiogenic effect, anti-inflammatory effect, regenerative effect, and survival after transplantation are also significantly enhanced in spheroids. Thus, 3D culture is a novel approach in cell-based therapeutics applicable in the field of regenerative medicine and tissue engineering, immunomodulatory diseases and organ transplantation for improved therapeutic outcomes. Various mechanism and techniques have been described for the formation of spheroids in different studies, some of which are discussed here. However, the molecular mechanism underlying the improved functionality and other changes is still unclear and requires further research. Similarly, clinically relevant studies are required to establish the clinical applicability.
引用
收藏
页码:1037 / 1046
页数:10
相关论文
共 171 条
  • [1] Morphological and Functional Analysis of Hepatocyte Spheroids Generated on Poly-HEMA-Treated Surfaces under the Influence of Fetal Calf Serum and Nonparenchymal Cells
    Acikgoez, Ali
    Giri, Shibashish
    Cho, Man-Gi
    Bader, Augustinus
    [J]. BIOMOLECULES, 2013, 3 (01): : 242 - 269
  • [2] Physical, Spatial, and Molecular Aspects of Extracellular Matrix of In Vivo Niches and Artificial Scaffolds Relevant to Stem Cells Research
    Akhmanova, Maria
    Osidak, Egor
    Domogatsky, Sergey
    Rodin, Sergey
    Domogatskaya, Anna
    [J]. STEM CELLS INTERNATIONAL, 2015, 2015
  • [3] Therapeutic implications of cancer stem cells
    Al-Hajj, M
    Becker, MW
    Wichal, M
    Weissman, I
    Clarke, MF
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) : 43 - 47
  • [4] Amos PJ, 2010, TISSUE ENG PT A, V16, P1595, DOI 10.1089/ten.TEA.2009.0616
  • [5] Mesenchymal stem cell therapy: Two steps forward, one step back
    Ankrum, James
    Karp, Jeffrey M.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2010, 16 (05) : 203 - 209
  • [6] Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness
    Baer, Patrick C.
    Griesche, Nadine
    Luttmann, Werner
    Schubert, Ralf
    Luttmann, Arlette
    Geiger, Helmut
    [J]. CYTOTHERAPY, 2010, 12 (01) : 96 - 106
  • [7] Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device
    Bagley, J
    Rosenzweig, M
    Marks, DF
    Pykett, MJ
    [J]. EXPERIMENTAL HEMATOLOGY, 1999, 27 (03) : 496 - 504
  • [8] Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro
    Baharvand, Hossein
    Hashemi, Seyed M.
    Kazemi Ashtian, Saeid
    Farrokhi, Ali
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2006, 50 (07) : 645 - 652
  • [9] An FDA perspective on preclinical development of cell-based regenerative medicine products
    Bailey, Alexander M.
    Mendicino, Michael
    Au, Patrick
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (08) : 721 - 723
  • [10] IS MY PRODUCT CAPABLE OF TUMOR FORMATION?
    Bailey, Alexander M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (147)